scholarly journals Could Baroreceptor Activation Therapy Be the Future for Treating Hypertension and Other Chronic Cardiovascular Conditions?

2010 ◽  
Vol 12 (4) ◽  
pp. 288-291 ◽  
Author(s):  
C. Venkata S. Ram
Hypertension ◽  
2017 ◽  
Vol 69 (5) ◽  
pp. 836-843 ◽  
Author(s):  
Peter W. de Leeuw ◽  
John D. Bisognano ◽  
George L. Bakris ◽  
Mitra K. Nadim ◽  
Hermann Haller ◽  
...  

2021 ◽  
Vol 16 ◽  
Author(s):  
Moisés Rodríguez-Mañero ◽  
Jose Luis Martínez-Sande ◽  
Javier García-Seara ◽  
Teba González-Ferrero ◽  
José Ramón González-Juanatey ◽  
...  

In this review, the authors describe evolving alternative strategies for the management of AF, focusing on non-invasive and percutaneous autonomic modulation. This modulation can be achieved – among other approaches – via tragus stimulation, renal denervation, cardiac afferent denervation, alcohol injection in the vein of Marshall, baroreceptor activation therapy and endocardial ganglionated plexi ablation. Although promising, these therapies are currently under investigation but could play a role in the treatment of AF in combination with conventional pulmonary vein isolation in the near future.


Sign in / Sign up

Export Citation Format

Share Document